ACATIS Investment 2024 Q2 (CRBU)
Pitch Summary: Caribou Bioscience uses advanced CRISPR technologies to develop new and targeted cancer treatments. These allogenic (i.e. non-individualised) CART therapies use advanced gene editing techniques to improve the immune response and increase anti-tumour activity. BSD Analysis: Caribou Biosciences has recently been upgraded to a “Buy” (Zacks Rank #2), reflecting a significant upward trend in […]
ClearPoint Neuro, Inc. (CLPT) – mike
Pitch Summary: @mike98572986 highlights multiple positive developments in CNS gene therapy that reinforce the value of ClearPoint Neuro’s delivery platform. The post points to AskBio’s Parkinson’s gene therapy receiving accelerated regulatory designation in Japan, signaling growing global momentum for advanced CNS treatments. Additional commentary on Huntington’s disease data emphasizes unexpectedly strong patient outcomes over multi-year […]
